Private Equity
Cressey & Company has acquired Chicago-based Elite Dental Partners, a dental support organization. The sellers include Tyree & D'Angelo Partners. No financial terms were disclosed. Houlihan Lokey was financial adviser to Elite Dental on the transaction while Golub Capital provided debt financing.
4 min read · 13 June 2018
Clayton, Dubilier & Rice and Cardinal Health Inc will jointly invest in Brentwood, Tennessee-based naviHealth, a manager of post-acute benefits for health plans. No financial terms were disclosed. According to terms of the deal, CD&R will acquire about a 55 percent ownership stake in naviHealth while Cardinal Health will retain an approximate 45 percent stake in the company. The transaction is expected to close in the third quarter of this year.
4 min read · 13 June 2018
2 min read · 13 June 2018
Leerink Revelation Partners has closed its second fund at a hard cap of $227 million, beating its target of $200 million. Leerink Revelation Healthcare Fund II will focus on secondary investments in healthcare. Leerink Revelation Partners is an investment partnership formed between Leerink Capital Partners and Revelation Partners to provide funding to healthcare investors, funds, founders and companies.
3 min read · 12 June 2018
2 min read · 11 June 2018
2 min read · 11 June 2018
The Riverside Company has acquired La Ventana Treatment Programs, a California-based provider of eating disorder programs, as an add-on for its Castlewood platform. No financial terms were disclosed.
2 min read · 11 June 2018
Chicagoland Smile Group, a portfolio company of Shore Capital Partners, has acquired Advanced Family Dental and Orthodontics, an Illinois-based provider of dentistry services. No financial terms were disclosed. Allen Mooney Barnes Brokerage Services provided financial advice to AFD on the deal.
3 min read · 11 June 2018
WebMD Health Corp, which is owned by Internet Brands, has acquired New York City-based Jobson Healthcare Information, a provider of information, education and marketing services in key healthcare markets. No financial terms were disclosed. JEGI advised JHI on the transaction. Internet Brands is a portfolio company of KKR and Temasek.
3 min read · 11 June 2018
London-based Autolus, a biopharmaceutical company focused on developing and commercializing T-cell therapies, is expecting to price its IPO of 7.8 million shares at between $15 and $17 per share. The stock will trade on the NASDAQ under the ticker symbol "AUTL." Goldman Sachs and Jefferies LLC are serving as lead underwriters. Autolus’ backers include Arix Bioscience plc, Cormorant Asset Management, Nextech Invest, Syncona and Woodford Investment Management.
3 min read · 11 June 2018
